87 related articles for article (PubMed ID: 24051218)
21. Molecular targeted therapies for diffuse large B-cell lymphoma based on apoptosis profiles.
Cillessen SA; Meijer CJ; Notoya M; Ossenkoppele GJ; Oudejans JJ
J Pathol; 2010 Apr; 220(5):509-20. PubMed ID: 20087881
[TBL] [Abstract][Full Text] [Related]
22. Comparison of outcomes after allogeneic hematopoietic stem cell transplantation in patients with follicular lymphoma, diffuse large B-cell lymphoma associated with follicular lymphoma, or de novo diffuse large B-cell lymphoma.
Tada K; Kim SW; Asakura Y; Hiramoto N; Yakushijin K; Kurosawa S; Tajima K; Mori S; Heike Y; Tanosaki R; Maeshima AM; Taniguchi H; Furuta K; Kagami Y; Matsuno Y; Tobinai K; Takaue Y; Fukuda T
Am J Hematol; 2012 Aug; 87(8):770-5. PubMed ID: 22641292
[TBL] [Abstract][Full Text] [Related]
23. Expression of a soluble decoy receptor 3 in patients with diffuse large B-cell lymphoma predicts clinical outcome.
Chang PM; Chen PM; Hsieh SL; Tzeng CH; Liu JH; Chiou TJ; Wang WS; Yen CC; Gau JP; Yang MH
Int J Oncol; 2008 Sep; 33(3):549-54. PubMed ID: 18695885
[TBL] [Abstract][Full Text] [Related]
24. Primary testicular diffuse large B-cell lymphoma shows an activated B-cell-like phenotype.
Li D; Xie P; Mi C
Pathol Res Pract; 2010 Sep; 206(9):611-5. PubMed ID: 20627604
[TBL] [Abstract][Full Text] [Related]
25. Molecular pathogenesis of diffuse large B-cell lymphoma.
Lossos IS
J Clin Oncol; 2005 Sep; 23(26):6351-7. PubMed ID: 16155019
[TBL] [Abstract][Full Text] [Related]
26. Diffuse large B-cell lymphoma of the orbit: clinicopathologic, immunohistochemical, and prognostic features of 20 cases.
Stacy RC; Jakobiec FA; Herwig MC; Schoenfield L; Singh A; Grossniklaus HE
Am J Ophthalmol; 2012 Jul; 154(1):87-98.e1. PubMed ID: 22503694
[TBL] [Abstract][Full Text] [Related]
27. Cytogenetics and molecular cytogenetics in diffuse large B-cell lymphoma (DLBCL).
Nedomova R; Papajik T; Prochazka V; Indrak K; Jarosova M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Sep; 157(3):239-47. PubMed ID: 23132512
[TBL] [Abstract][Full Text] [Related]
28. Comparative clinicopathological study of primary CNS diffuse large B-cell lymphoma and intravascular large B-cell lymphoma.
Imai H; Shimada K; Shimada S; Abe M; Okamoto M; Kitamura K; Kinoshita T; Shiraishi T; Nakamura S
Pathol Int; 2009 Jul; 59(7):431-7. PubMed ID: 19563405
[TBL] [Abstract][Full Text] [Related]
29. Microscopic diffuse large B-cell lymphoma (DLBCL) occurring in pseudocysts: do these tumors belong to the category of DLBCL associated with chronic inflammation?
Boroumand N; Ly TL; Sonstein J; Medeiros LJ
Am J Surg Pathol; 2012 Jul; 36(7):1074-80. PubMed ID: 22472958
[TBL] [Abstract][Full Text] [Related]
30. Hyperactivated STAT3 in ALK-positive diffuse large B-cell lymphoma with clathrin-ALK fusion.
Momose S; Tamaru J; Kishi H; Mikata I; Mori M; Toyozumi Y; Itoyama S
Hum Pathol; 2009 Jan; 40(1):75-82. PubMed ID: 18755494
[TBL] [Abstract][Full Text] [Related]
31. Recent advances in the understanding and management of diffuse large B-cell lymphoma in children.
Reiter A; Klapper W
Br J Haematol; 2008 Jul; 142(3):329-47. PubMed ID: 18537979
[TBL] [Abstract][Full Text] [Related]
32. [SOCSJ gene mutations in patients with diffuse large B-cell lymphoma].
Gavrilina OA; Zvonkov EE; Biderman BV; Severina NA; Parovichnikova EN
Ter Arkh; 2015; 87(7):105-111. PubMed ID: 26390734
[TBL] [Abstract][Full Text] [Related]
33. Molecular subtyping of diffuse large B-cell lymphoma: update on biology, diagnosis and emerging platforms for practising pathologists.
Gifford GK; Gill AJ; Stevenson WS
Pathology; 2016 Jan; 48(1):5-16. PubMed ID: 27020203
[TBL] [Abstract][Full Text] [Related]
34. Molecular signatures define new rational treatment targets in large B-cell lymphomas.
Shipp MA
Hematology Am Soc Hematol Educ Program; 2007; ():265-9. PubMed ID: 18024639
[TBL] [Abstract][Full Text] [Related]
35. Beyond genomics - Targeting the epigenome in diffuse large B-cell lymphoma.
Kühnl A; Cunningham D; Chau I
Cancer Treat Rev; 2017 Sep; 59():132-137. PubMed ID: 28822237
[TBL] [Abstract][Full Text] [Related]
36. Diffuse large B-cell lymphoma: the history, current view and new perspectives.
Flodr P; Latalova P; Tichy M; Kubova Z; Papajik T; Svachova M; Vrzalikova K; Radova L; Jarosova M; Murray P
Neoplasma; 2014; 61(5):491-504. PubMed ID: 25030433
[TBL] [Abstract][Full Text] [Related]
37. [Molecular classification and its clinical relevance in diffuse large B-cell lymphoma].
Ennishi D
Rinsho Ketsueki; 2019; 60(9):1186-1192. PubMed ID: 31597842
[TBL] [Abstract][Full Text] [Related]
38. The value of liquid biopsy in diagnosis and monitoring of diffuse large b-cell lymphoma: recent developments and future potential.
Camus V; Jardin F; Tilly H
Expert Rev Mol Diagn; 2017 Jun; 17(6):557-566. PubMed ID: 28415895
[TBL] [Abstract][Full Text] [Related]
39. Diffuse large B-cell lymphomas, not otherwise specified, and emerging entities.
Song JY; Dirnhofer S; Piris MA; Quintanilla-Martínez L; Pileri S; Campo E
Virchows Arch; 2023 Jan; 482(1):179-192. PubMed ID: 36459219
[TBL] [Abstract][Full Text] [Related]
40. Report of the first workshop on prognostic factors in large-cell lymphomas.
Coiffier B; Shipp MA; Cabanillas F; Crowther D; Armitage JO; Canellos GP
Ann Oncol; 1991 Feb; 2 Suppl 2():213-7. PubMed ID: 1675583
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
